Bharat Biotech to slash malaria vaccine prices by 2028
The announcement was made by Bharat Biotech and GSK as a part of Gavi, the Vaccine Alliance, for its next replenishment phase (Gavi 6.0, 2026-2030) by both companies.
Dr. Krishna Ella, Executive Chairman of Bharat Biotech International Limited said: 'This pledge to Gavi 6.0 is more than a pricing announcement. It is a commitment to global equity and innovation.
Through this historic announcement, we aim to change the course of malaria burden for millions of children and families. For us, this is more than a cooperation, By joining forces with GSK, and working closely with Gavi, and the WHO, we are taking a real step toward closing the gap between vaccine supply and the urgent needs of children at risk of malaria.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
6 days ago
- First Post
As US & UK cut funds to Gavi, millions risk losing access to vaccines
As the United States and United Kingdom have cut billions in funds to Gavi, the global vaccination partnership, millions of people across the world are set to lose access to affordable vaccines and hundreds of thousands are at the risk of dying. read more A woman holds her baby as she receives a shot of the Johnson & Johnson vaccine against the coronavirus disease (COVID-19) in the Mavrovouni camp on Lesbos, Greece. (Alkis Konstantinidis/Reuters) The United States and the United Kingdom have announced cuts to their donations to Gavi, the global vaccination partnership, putting millions across the world at the risk of losing access to affordable vaccines. While American cuts are rooted in the anti-vaccine stance of the Donald Trump administration, British cuts are a result of diversion of funds from foreign aid towards defence in the wake of the increasing security threats from the likes of Russia and China. STORY CONTINUES BELOW THIS AD US Health Secretary Robert F Kennedy Junior has announced the administration will cut around $300 million in annual donations to Gavi, according to Reuters. The UK has slashed its donations annual contribution to Gavi for the next five years from $438.4 million to $342.5 million, according to The Daily Telegraph. Estimates have said that millions of people across the world are at the risk of losing access affordable vaccines and hundreds of thousands are at the risk of dying as a result of cuts. 350,000 children at risk of dying, says estimate Gavi serves some of the poorest people of the world and they are bound to be hit the hardest. The British cuts alone will threaten 23 million child vaccinations over the next five years and potentially cause 350,000 additional deaths, The Telegraph reported the ONE campaign's estimate as saying. Gavi has been distributing vaccines for diseases like HPV, malaria, yellow fever, COVID-19, Ebola, measles, and typhoid, in some of the poorest communities of the world. It relies on support from countries and philanthropies. British International Development Minister Baroness Jenny Chapman told The Telegraph that the cuts are a result of some 'really tough choices' the government had to make. 'We've had to make some really tough choices. But we've decided as a government that we want to invest in defence, because that's the world we are in When we cut the aid budget, we knew we'd have to cut things that are globally good. Gavi would be something it would be great to put more money into in future and I hope we can, but for today this is a good pledge from the UK,' said Chapman. STORY CONTINUES BELOW THIS AD China to gain at cost of US & UK The US vaccine aid cuts are part of the broader foreign aid cuts under the Trump administration. The Trump administration has hollowed out the US AID that ran the foreign aid programme and has withdrawn from large parts of the world, compromising healthcare, nutritional, and developmental programmes in some of the most vulnerable communities in the world. The US withdrawal from the world, particularly in the poor and developing parts of the world, will create a vacuum that China will rush to fill in, making foreign aid cuts a self-goal by Trump, Tej Pratap Singh, a scholar of China at the Department of Political Science, Banaras Hindu University, previously told Firstpost. Humanitarian operations are instruments to peddle soft power the world over and the shutting down of humanitarian operations anywhere is a self-goal, said Singh. 'Developing countries need assistance. If the United States withdraws, China will reach out to these nations and they will be glad to have Chinese support. China has been making inroads in Africa for many years and the US withdrawal is set to increase that. India has been countering Chinese influence in the Global South but countering China needs joint efforts and, in the absence of US involvement, China is set to make good gains,' said Singh. STORY CONTINUES BELOW THIS AD
&w=3840&q=100)
Business Standard
6 days ago
- Business Standard
US pulls funding from vaccines group; 'ignored the science', says RFK Jr
US Health Secretary Robert F Kennedy Jr said the country is pulling its support from the vaccines alliance Gavi, saying the organisation has ignored the science and lost the public trust. A video of Kennedy's speech was shown to participants at a Gavi meeting in Brussels on Wednesday, where the vaccines group was hoping to raise at least $9 billion for the next five years. Gavi is a public-private partnership including WHO, UNICEF, the Gates Foundation and the World Bank. It has paid for more than 1 billion children to be vaccinated through routine immunisation programmes, saving an estimated 18 million lives. The US has long been one of its biggest supporters; before Trump's re-election, the country had pledged $ 1 billion through 2030. Kennedy called on Gavi to re-earn the public trust and to justify the $ 8 billion America has provided in funding since 2001, saying officials must consider the best science available, even when that science contradicts established paradigms. Kennedy said until that happens, the US won't contribute further to Gavi. Kennedy, a longtime vaccine sceptic, said he and President Trump were concerned about how Gavi and the World Health Organisation partnered together during the COVID-19 pandemic to work with social media companies to silence dissenting views, to stifle free speech and legitimate questions during a time when many people had questions about vaccine safety. Kennedy said Gavi continues to make questionable recommendations, like advising pregnant women to get immunized against COVID-19 and funding the roll-out of a vaccine against diphtheria, tetanus and pertussis in poorer countries. WHO and other health authorities have recommended pregnant women get vaccinated against COVID-19, saying they are at higher risk of severe disease. Kennedy said he has seen research that concluded that young girls vaccinated against diphtheria, tetanus and pertussis were more likely to die from all other causes than children who weren't immunized. Gavi said in a statement Thursday that its utmost concern is the health and safety of children. The organisation said any decision it makes on vaccines to buy is done in accordance with recommendations issued by WHO's expert vaccine group. This ensures Gavi investments are grounded in the best available science and public health priorities, it said. Gavi said scientists had reviewed all available data, including any studies that raised concerns, and that the diphtheria, tetanus and pertussis vaccine has played a key role in helping halve childhood mortality. The British government said Wednesday it would give 1.25 billion pounds ($ 1.7 billion) between 2026 and 2030 to Gavi. It said the money would help Gavi protect up to 500 million children in some of the world's poorest countries from diseases including meningitis, cholera and measles.
New Indian Express
7 days ago
- New Indian Express
Bharat Biotech to slash malaria vaccine prices by 2028
HYDERABAD: Bharat Biotech International Limited (BBIL) and GSK plc on Wednesday announced a price reduction on the world's first malaria vaccine, RTS.S. The vaccine developed by GSK, PATH and partners will have a price reduction of $5 progressively by 2028. The price reduction is driven by process improvements, expanded production capacity, cost- effective manufacturing. The announcement was made by Bharat Biotech and GSK as a part of Gavi, the Vaccine Alliance, for its next replenishment phase (Gavi 6.0, 2026-2030) by both companies. Dr. Krishna Ella, Executive Chairman of Bharat Biotech International Limited said: 'This pledge to Gavi 6.0 is more than a pricing announcement. It is a commitment to global equity and innovation. Through this historic announcement, we aim to change the course of malaria burden for millions of children and families. For us, this is more than a cooperation, By joining forces with GSK, and working closely with Gavi, and the WHO, we are taking a real step toward closing the gap between vaccine supply and the urgent needs of children at risk of malaria.
